RT Journal Article
SR Electronic
A1 Vinall, Maria
A1 Sinclair, Heather Q.
T1 Optimizing Diabetes Management
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 2
SP 23
OP 24
DO 10.1177/155989771002016
UL http://mdc.sagepub.com/content/10/2/23.abstract
AB Cardiovascular disease (CVD) is one of the primary clinical risks that are associated with type 2 diabetes. While a clear graded association of CVD risk has been noted with hyperglycemia, the role of glucose control in CVD risk mitigation remains uncertain. This article discusses data from the UK Prospective Diabetes Study [UKPDS] Group, the relationship between atherosclerosis and diabetes, the ARBITER 6-HALTS Trial, and blood glucose control by sulphonylureas or insulin.